TrialBreast cancer research and treatment2011

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.

Suleiman Massarweh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.